XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Revenues $ 20,900 $ 43,488 $ 125,881
Research and development expenses 534,317 635,478 1,818,108 1,833,841
Selling and marketing expenses 265,282 465,814 857,386 1,064,048
General and administrative expenses 811,695 1,567,970 2,894,553 5,124,048
Total operating expenses 1,611,294 2,669,262 5,570,847 8,021,937
Operating loss (1,611,106) (2,648,362) (5,527,171) (7,896,056)
Financing income, net 38,228 63,622 144,016 223,790
Loss for the period (1,572,878) (2,584,740) (5,383,155) (7,672,266)
Other comprehensive income:        
Foreign currency translation adjustment 4,740 (12,076) 40,370 52,360
Comprehensive loss for the period $ (1,568,138) $ (2,596,816) $ (5,342,785) $ (7,619,906)
Loss per share (Basic) $ (0.31) $ (0.44) $ (0.96) $ (1.40)
Loss per share (Diluted) $ (0.31) $ (0.44) $ (0.96) $ (1.40)
Common shares used in computing Basic income (loss) per share 8,249,442 6,386,772 7,745,275 6,207,844
Common shares used in computing Diluted income (loss) per share 8,249,442 6,386,772 7,745,275 6,207,844